AGP Picks
View all

Mississippi Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mississippi Healthcare Reporter.

Press releases published on July 31, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Precipio Announces Q2-2026 Shareholder Update Call
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients
Human Appeal USA Announces "The Biggest Comedy Show" 2026 Tour: A 25-City Nationwide Event Where Every Laugh Gives Back to Global Humanitarian Relief
Redwoods Press, LLC Launches Innovative Journal for Family Caregivers
Moleculin Announces Pricing of $9.3 Million Public Offering 
Single-use Technologies for Biopharmaceuticals Market to Reach $16.31 Billion by 2031, Driven by Growing Monoclonal Antibody Production
Turkish Airlines Sports Club Women’s Volleyball Team Completes Pre-Season Health Checks at Medicana
Electrophysiology Market to Grow from USD 12.55 Billion in 2025 to USD 21.72 Billion by 2030, at a CAGR of 11.6% – MarketsandMarkets™
Rose Hill Life Sciences and Control Z Sign Letter of Intent to Advance Clinically Structured Psilocybin-Assisted Therapy for PTSD
Former First Baptist Medical Center Acquired By St Raphael Health - Dallas
NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing
Stablecoin Development Corporation Reports Second Quarter 2026 Financial Results
Vistagen Appoints Douglas J. Williamson to its Board of Directors
NOMAD Power Solutions Announces Options Trading Begins on Cboe Options Exchange
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
Cerenome Launches as an Integrated CNS Oncology Company
SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
Moleculin’s MIRACLE R/R AML Trial Reports Positive Interim Data with 37% Blinded CRc in Venetoclax-Failed Patients

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Mississippi Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.